FDA/M-CERSI Co-Processed API Workshop Proceedings-Reference-Cited by-同舟云学术

FDA/M-CERSI Co-Processed API Workshop Proceedings

Published:2023-08 Issue:8 Volume:112 Page:2069-2078
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Schenck Luke^ORCID,Patel Paresma,Sood Ramesh,Bonaga Llorente,Capella Peter,Dirat Olivier^ORCID,Erdemir Deniz^ORCID,Ferguson Steven,Gazziola Cinzia,Gorka Lindsey Saunders,Graham Laurie,Ho Raimundo,Hoag Stephen^ORCID,Hunde Ephrem,Kline Billie,Lee Sau (Larry),Madurawe Rapti,Marziano Ivan,Merritt Jeremy Miles,Page Sharon,Polli James^ORCID,Ramanadham Mahesh,Sapru Mohan,Stevens Ben,Watson Tim,Zhang Haitao

Funder

U.S. Food and Drug Administration

U.S. Department of Health and Human Services

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference42 articles.

1. Recent advances in co-processed APIs and proposals for enabling commercialization of these transformative technologies;Schenck;Mol Pharmaceutics,2020

2. Toward a single global control strategy: industry study;Beierle;Pharm Eng,2022

3. 2019 FDA Drug approval;Mullard;Nat Rev Drug Discov,2020

4. The expanding role of prodrugs in contemporary drug design and development;Rautio;Nat Rev Drug Discov,2018

5. Beyond the rule of 5: lessons learned from AbbVie's drugs and compound collection;DeGoey;J Med Chem,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Morphological Population Balance to Develop a Model-Driven Quality-by-Design Approach for Crystallization Processes;Crystal Growth & Design;2024-05-27

2. A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical Industry;Journal of Pharmaceutical Sciences;2023-12